IL235459A0 - Ways to treat non-small cell lung cancer - Google Patents

Ways to treat non-small cell lung cancer

Info

Publication number
IL235459A0
IL235459A0 IL235459A IL23545914A IL235459A0 IL 235459 A0 IL235459 A0 IL 235459A0 IL 235459 A IL235459 A IL 235459A IL 23545914 A IL23545914 A IL 23545914A IL 235459 A0 IL235459 A0 IL 235459A0
Authority
IL
Israel
Prior art keywords
lung cancer
small cell
cell lung
treating non
treating
Prior art date
Application number
IL235459A
Other languages
English (en)
Hebrew (he)
Inventor
Chen Duksin
Shoshi Tessler
Original Assignee
Teva Pharma
Chen Duksin
Shoshi Tessler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma, Chen Duksin, Shoshi Tessler filed Critical Teva Pharma
Publication of IL235459A0 publication Critical patent/IL235459A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/713Double-stranded nucleic acids or oligonucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088Compounds having three or more nucleosides or nucleotides
    • A61K31/7105Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G01N33/5752

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL235459A 2012-05-18 2014-11-02 Ways to treat non-small cell lung cancer IL235459A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261649092P 2012-05-18 2012-05-18
PCT/US2013/041652 WO2013173757A1 (en) 2012-05-18 2013-05-17 Method for treating non-small cell lung cancer

Publications (1)

Publication Number Publication Date
IL235459A0 true IL235459A0 (en) 2014-12-31

Family

ID=49581824

Family Applications (1)

Application Number Title Priority Date Filing Date
IL235459A IL235459A0 (en) 2012-05-18 2014-11-02 Ways to treat non-small cell lung cancer

Country Status (17)

Country Link
US (1) US20130310440A1 (enExample)
EP (1) EP2849761A1 (enExample)
JP (1) JP2015522542A (enExample)
KR (1) KR20150024843A (enExample)
CN (1) CN104684564A (enExample)
AR (1) AR091090A1 (enExample)
AU (1) AU2013262589A1 (enExample)
BR (1) BR112014028787A2 (enExample)
CA (1) CA2874092A1 (enExample)
EA (1) EA201492148A1 (enExample)
IL (1) IL235459A0 (enExample)
IN (1) IN2014DN10390A (enExample)
PH (1) PH12014502569A1 (enExample)
SG (1) SG11201407649RA (enExample)
TW (1) TW201402132A (enExample)
UY (1) UY34812A (enExample)
WO (1) WO2013173757A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ513757A (en) 1999-02-26 2004-12-24 Univ British Columbia Antisense oligonucleotides to inhibit TRPM-2 expression and delay androgen independance in prostatic tumour cells
US7569551B2 (en) 2000-02-25 2009-08-04 The University Of British Columbia Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
KR101809623B1 (ko) 2010-05-08 2017-12-15 더 리전트 오브 더 유니버시티 오브 캘리포니아 궤양의 조기 발견을 위한 sem 스캐너 감지 장치, 시스템 및 방법
KR20140038388A (ko) 2011-03-15 2014-03-28 더 유니버시티 오브 브리티쉬 콜롬비아 전립선암의 치료를 위한 항-클러스테린 올리고뉴클레오타이드와 hsp90 저해제의 병용
CN104473973B (zh) * 2014-12-19 2015-08-05 山东创新药物研发有限公司 一株戈氏梭菌驯化株的应用
US10182740B2 (en) 2015-04-24 2019-01-22 Bruin Biometrics, Llc Apparatus and methods for determining damaged tissue using sub-epidermal moisture measurements
JP7105767B2 (ja) 2017-02-03 2022-07-25 ブルーイン、バイオメトリクス、リミテッド、ライアビリティー、カンパニー 糖尿病性足部潰瘍に対する感受性の測定
AU2018217187B2 (en) 2017-02-03 2020-01-02 Bruin Biometrics, Llc Measurement of edema
DK3515296T3 (da) 2017-02-03 2023-11-27 Bbi Medical Innovations Llc Måling af vævslevedygtighed
GB2575186B (en) 2017-11-16 2020-06-03 Bruin Biometrics Llc Strategic treatment of pressure ulcer using sub-epidermal moisture values
WO2019136287A1 (en) * 2018-01-05 2019-07-11 LifeUnit Inc. Adjuvant chemicals that prevent drug tolerance and persister formation by bacteria
PT3749181T (pt) 2018-02-09 2024-05-15 Bruin Biometrics Llc Deteção de lesões nos tecidos
PT4283799T (pt) 2018-10-11 2025-04-23 Bruin Biometrics Llc Dispositivo com elemento descartável
WO2022169850A1 (en) 2021-02-03 2022-08-11 Bruin Biometrics, Llc Methods of treating deep and early-stage pressure induced tissue damage

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6900187B2 (en) * 1999-02-26 2005-05-31 The University Of British Columbia TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
US8710020B2 (en) * 2004-04-02 2014-04-29 The University Of British Columbia Clusterin antisense therapy for treatment of cancer
WO2009155381A1 (en) * 2008-06-18 2009-12-23 Abbott Laboratories P/gf-1 companion diagnostic methods and products
AU2012257487A1 (en) * 2011-05-19 2014-01-16 Teva Pharmaceutical Industries Ltd. Method for treating non-small cell lung cancer

Also Published As

Publication number Publication date
KR20150024843A (ko) 2015-03-09
JP2015522542A (ja) 2015-08-06
UY34812A (es) 2013-12-31
SG11201407649RA (en) 2014-12-30
AR091090A1 (es) 2014-12-30
EP2849761A1 (en) 2015-03-25
US20130310440A1 (en) 2013-11-21
WO2013173757A8 (en) 2015-04-30
AU2013262589A1 (en) 2015-01-22
PH12014502569A1 (en) 2015-01-21
TW201402132A (zh) 2014-01-16
BR112014028787A2 (pt) 2017-06-27
EA201492148A1 (ru) 2015-04-30
CA2874092A1 (en) 2013-11-21
IN2014DN10390A (enExample) 2015-08-14
WO2013173757A1 (en) 2013-11-21
CN104684564A (zh) 2015-06-03

Similar Documents

Publication Publication Date Title
IL288181A (en) Cancer treatment methods
IL274647A (en) Methods for treating non- small cell lung cancer using tor kinase inhibitor combination therapy
IL235459A0 (en) Ways to treat non-small cell lung cancer
IL237791A0 (en) A method for treating cancer
PL3967315T3 (pl) Akkermansia muciniphila do leczenia nowotworu złośliwego
SG11201503893RA (en) Method of treating cancer
ZA201501914B (en) Method for enhancing specific immunotherapies in cancer treatment
IL235696A0 (en) A method for treating gd2 positive cancer
PL2542585T3 (pl) Sposoby leczenia nowotworu jelita grubego
ZA201906339B (en) Methods for treating pruritus
ZA201309254B (en) Method for treating non-small cell lung cancer
EP2895206A4 (en) METHOD FOR TREATING CARCINOMA
IL228644A0 (en) Cancer treatment methods
PL2876447T3 (pl) Sposób wykrywania nowotworu
IL254964A0 (en) A method for treating breast cancer
GB2503068B (en) Ion guide construction method
PL2754441T3 (pl) Kompozycja do profilaktyki i leczenia niedrobnokomórkowego raka płuc, zawierająca pochodne pirazyno-triazynowe
GB2523708B (en) Method for ion production
EP2882420A4 (en) IMPROVED METHODS OF TREATING CANCER WITH REDUCED RENALER TOXICITY
HK1195735A (en) Method for treating non-small cell lung cancer
AU2012901918A0 (en) Methods for treating cancer
EP2707011A4 (en) METHOD FOR THE TREATMENT OF PROSTATE CANCER
GB201205136D0 (en) Ion guide construction method
IL232266A0 (en) Cancer treatment methods